Andrea Veatch
Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Andrea Veatch

Oncology
CommonSpirit Health
Northwest Medical Specialties - Puyallup
Puyallup, WA 
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
CommonSpirit Health
Northwest Medical Specialties - Puyallup
Puyallup, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrea Veatch is an Oncologist in Puyallup, Washington. Dr. Veatch is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Dehydration, and Testicular Yolk Sac Tumor. Dr. Veatch is currently accepting new patients.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Minnesota, Minneapolis, MN
Residency
Mt. Sinai Medical Center
Specialties
Oncology
Licenses
Internal Medicine in WA
Fellowships
Fred Hutchinson Cancer Research Center, Seattle, WA
Hospital Affiliations
Tacoma General Allenmore Hospital
St Joseph Medical Center
St Clare Hospital
Multicare Good Samaritan Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Contra Costa Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Northwest Medical Specialties - Puyallup
Puyallup, WA 98373
Call: 253-841-4296

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Drug
Study Drugs: TSR-022, Nivolumab, TSR-042, TSR-033, Docetaxel
Study Phase: Phase 1
A Multicenter, Open-label, Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv Squamous Cell Carcinoma of H&N (SCCHN) Who Failed Pembro Monotherapy or Experiencing SD Following Completion of 4 to 8 Cycles of Pembro Monotherapy
A Multicenter, Open-label, Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv Squamous Cell Carcinoma of H&N (SCCHN) Who Failed Pembro Monotherapy or Experiencing SD Following Completion of 4 to 8 Cycles of Pembro Monotherapy
Enrollment Status: Terminated
Publish Date: December 14, 2018
Intervention Type: Biological, Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

2 Total Publications

Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study.
Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 23, 2024
View All 2 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Scott S. Tykodi
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Scott S. Tykodi
Oncology

The Association Of University Physicians

825 Eastlake Ave E, 
Seattle, WA 
 (26.8 miles away)
206-288-1000
Languages Spoken:
English, French, Polish, Portuguese, Russian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Tykodi is an Oncologist in Seattle, Washington. Dr. Tykodi is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Adult Soft Tissue Sarcoma, and Nephrectomy. Dr. Tykodi is currently accepting new patients.

John P. Flores
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. John P. Flores
Oncology | Neurology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. John P. Flores
Oncology | Neurology

Virginia Mason Medical Center

1100 Ninth Avenue, 
Seattle, WA 
 (25.7 miles away)
206-624-1144
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Paul Flores, MD, is a board-certified medical oncologist. He cares for patients with blood disorders and all forms of cancer.Dr. Flores takes the time to guide his patients on their wellness journey, listening to what they say, answering their questions and providing a path forward with hope. In this complex, fast-growing field where new treatments are approved for clinical use regularly, Dr. Flores relies on the expertise of a team of surgeons, pathologists, radiation oncologists and other colleagues to stay at the forefront of cancer treatment and to provide comprehensive, patient-centered care. Dr. Flores is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Prostatectomy, and Splenectomy.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Song Zhao
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Song Zhao
Oncology
1221 Madison Street, Arnold Pavilion, 
Anchorage, WA 
 (25.2 miles away)
206-215-2559
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Song Zhao is an Oncologist in Anchorage, Washington. Dr. Zhao is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Familial Prostate Cancer. Dr. Zhao is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Veatch's expertise for a condition
ConditionClose
    • Distinguished
    • Agranulocytosis
      Dr. Veatch is
      Distinguished
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Chronic Familial Neutropenia
      Dr. Veatch is
      Distinguished
      . Learn about Chronic Familial Neutropenia.
      See more Chronic Familial Neutropenia experts
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Veatch is
      Distinguished
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Colorectal Cancer
      Dr. Veatch is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Dehydration
      Dr. Veatch is
      Distinguished
      . Learn about Dehydration.
      See more Dehydration experts
    • Familial Colorectal Cancer
      Dr. Veatch is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    View All 15 Distinguished Conditions
    • Advanced
    • Adult Immune Thrombocytopenia
      Dr. Veatch is
      Advanced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Veatch is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anemia
      Dr. Veatch is
      Advanced
      . Learn about Anemia.
      See more Anemia experts
    • Breast Cancer
      Dr. Veatch is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Childhood Acute Myeloid Leukemia
      Dr. Veatch is
      Advanced
      . Learn about Childhood Acute Myeloid Leukemia.
      See more Childhood Acute Myeloid Leukemia experts
    • Childhood Iron Deficiency Anemia
      Dr. Veatch is
      Advanced
      . Learn about Childhood Iron Deficiency Anemia.
      See more Childhood Iron Deficiency Anemia experts
    View All 55 Advanced Conditions
    • Experienced
    • Acinic Cell Carcinoma of Salivary Glands
      Dr. Veatch is
      Experienced
      . Learn about Acinic Cell Carcinoma of Salivary Glands.
      See more Acinic Cell Carcinoma of Salivary Glands experts
    • Acute Arterial Occlusion of Kidney
      Dr. Veatch is
      Experienced
      . Learn about Acute Arterial Occlusion of Kidney.
      See more Acute Arterial Occlusion of Kidney experts
    • Acute Mountain Sickness
      Dr. Veatch is
      Experienced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Veatch is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Veatch is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Veatch is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    View All 150 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved